A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia

INTRODUCTION: Behavioural variant frontotemporal dementia (bvFTD) is a neurodegenerative disorder often neuropathologically associated with the accumulation of abnormally hyperphosphorylated tau, for which there is currently no disease-modifying treatment. Previous work by our group has shown sodium...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivash, Lucy, Malpas, Charles B, Churilov, Leonid, Walterfang, Mark, Brodtmann, Amy, Piguet, Olivier, Ahmed, Rebekah M, Bush, Ashley I, Hovens, Christopher M, Kalincik, T, Darby, David, Velakoulis, Dennis, O'Brien, Terence J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670941/
https://www.ncbi.nlm.nih.gov/pubmed/33199422
http://dx.doi.org/10.1136/bmjopen-2020-040100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670941/
https://www.ncbi.nlm.nih.gov/pubmed/33199422
http://dx.doi.org/10.1136/bmjopen-2020-040100

Ejemplares similares